Skip to main content

Table 5 Comparison of Length of Inpatient Stay and Number of Hospitalizations After Switching to PP1M in Patients with ≥ 1 Inpatient Stay in Period A

From: A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China

  Number of hospitalizations Inpatient stays (days)
pre-PP1M 0.67±0.96 52.80±60.54
Post-PP1M 0.22±0.42 16.33±29.48
T 2.56 1.73
P ≤ 0.01 < 0.05